New York City-based Minded Inc. secured $25 million in seed funding to help it expand the geographic reach and impact of its telepsychiatry and medication management platform. Minded plans to expand into more states in the U.S. as well as add mood, attention-deficit treatments and psychedelic treatments to its offerings; and offer genetic testing for […]